These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31747808)

  • 1. Is immunotherapy the holy grail for pancreatic cancer?
    Andersson R; Pereira CF; Bauden M; Ansari D
    Immunotherapy; 2019 Dec; 11(17):1435-1438. PubMed ID: 31747808
    [No Abstract]   [Full Text] [Related]  

  • 2. Dilemma and Challenge of Immunotherapy for Pancreatic Cancer.
    Wu J; Cai J
    Dig Dis Sci; 2021 Feb; 66(2):359-368. PubMed ID: 32140943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational combinations of immunotherapy for pancreatic ductal adenocarcinoma.
    Blair AB; Zheng L
    Chin Clin Oncol; 2017 Jun; 6(3):31. PubMed ID: 28705008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the immune landscape and tumor microenvironment of pancreatic cancer to improve immunotherapy.
    Torphy RJ; Schulick RD; Zhu Y
    Mol Carcinog; 2020 Jul; 59(7):775-782. PubMed ID: 32166821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy for pancreatic cancer: present and future.
    Aroldi F; Zaniboni A
    Immunotherapy; 2017 Jun; 9(7):607-616. PubMed ID: 28595517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune-based therapies in pancreatic and colorectal cancers and biomarkers of responsiveness.
    Di Caro G; Castino GF; Bergomas F; Cortese N; Chiriva-Internati M; Grizzi F; Marchesi F
    Expert Rev Anticancer Ther; 2014 Oct; 14(10):1219-28. PubMed ID: 25222571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy in pancreatic cancer: New hope or mission impossible?
    Jiang J; Zhou H; Ni C; Hu X; Mou Y; Huang D; Yang L
    Cancer Lett; 2019 Mar; 445():57-64. PubMed ID: 30641107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy for pancreatic cancer: A long and hopeful journey.
    Xu JW; Wang L; Cheng YG; Zhang GY; Hu SY; Zhou B; Zhan HX
    Cancer Lett; 2018 Jul; 425():143-151. PubMed ID: 29605510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial: Novel immunological characteristics and immunotherapeutic targets in pancreatic cancer.
    Khan HY; Lou Y; Sexton-Bonacci RE
    Front Immunol; 2024; 15():1428740. PubMed ID: 38887302
    [No Abstract]   [Full Text] [Related]  

  • 10. Strategies to relieve immunosuppression in pancreatic cancer.
    Schnurr M; Duewell P; Bauer C; Rothenfusser S; Lauber K; Endres S; Kobold S
    Immunotherapy; 2015; 7(4):363-76. PubMed ID: 25917628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging trends in the immunotherapy of pancreatic cancer.
    Banerjee K; Kumar S; Ross KA; Gautam S; Poelaert B; Nasser MW; Aithal A; Bhatia R; Wannemuehler MJ; Narasimhan B; Solheim JC; Batra SK; Jain M
    Cancer Lett; 2018 Mar; 417():35-46. PubMed ID: 29242097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholecystokinin receptor antagonist alters pancreatic cancer microenvironment and increases efficacy of immune checkpoint antibody therapy in mice.
    Smith JP; Wang S; Nadella S; Jablonski SA; Weiner LM
    Cancer Immunol Immunother; 2018 Feb; 67(2):195-207. PubMed ID: 29043413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viro-immune therapy: A new strategy for treatment of pancreatic cancer.
    Ibrahim AM; Wang YH
    World J Gastroenterol; 2016 Jan; 22(2):748-63. PubMed ID: 26811622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harnessing the Microbiome for Pancreatic Cancer Immunotherapy.
    Vitiello GA; Cohen DJ; Miller G
    Trends Cancer; 2019 Nov; 5(11):670-676. PubMed ID: 31735286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of the Microbiome in Immunologic Development and its Implication For Pancreatic Cancer Immunotherapy.
    Sethi V; Vitiello GA; Saxena D; Miller G; Dudeja V
    Gastroenterology; 2019 May; 156(7):2097-2115.e2. PubMed ID: 30768986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy of pancreatic cancer.
    Sunami Y; Kleeff J
    Prog Mol Biol Transl Sci; 2019; 164():189-216. PubMed ID: 31383405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy for pancreatic cancer: A 2020 update.
    Schizas D; Charalampakis N; Kole C; Economopoulou P; Koustas E; Gkotsis E; Ziogas D; Psyrri A; Karamouzis MV
    Cancer Treat Rev; 2020 Jun; 86():102016. PubMed ID: 32247999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy and Combination Strategies in Pancreatic Cancer: Current Status and Emerging Trends.
    Cheung PF; Lutz M; Siveke JT
    Oncol Res Treat; 2018; 41(5):286-290. PubMed ID: 29705789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in immunotherapy for pancreatic cancer: 2013.
    DeVito NC; Saif MW
    JOP; 2013 Jul; 14(4):347-53. PubMed ID: 23846925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD-1/PD-L1 and immunotherapy for pancreatic cancer.
    Feng M; Xiong G; Cao Z; Yang G; Zheng S; Song X; You L; Zheng L; Zhang T; Zhao Y
    Cancer Lett; 2017 Oct; 407():57-65. PubMed ID: 28826722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.